Overview

A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

To optimize Mycobacterium avium Complex (MAC) prophylaxis in AIDS patients by measuring serum rifabutin levels and adjusting the dose accordingly. To combine rifabutin with ethambutol to examine the effect of combination therapy in preventing or delaying the incidence of MAC bacteremia in this patient population.

Phase:

Phase 4

Details

Lead Sponsor:

Pharmacia

Treatments:

Ethambutol
Rifabutin